Cortical Activation During Walking in Stroke
Launched by NATIONAL YANG MING CHIAO TUNG UNIVERSITY · Feb 17, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how walking—both forward and backward—affects brain activity in people who have had a stroke. After a stroke, one side of the brain often becomes less active, which can slow down recovery. The researchers want to see if walking in different directions can help balance the brain's activity and improve movement skills. They hope to learn more about how treadmill training might help stroke patients regain their motor function by looking at brain activity during walking.
To be eligible for this study, participants need to be at least six months post-stroke and able to walk independently for at least 7 meters, with or without a walking aid. They should also have a good score on a mental health assessment. However, those who have difficulty walking backward, certain medical conditions, or disorders affecting vision or hearing will not be included. Participants will have the opportunity to contribute to important research that could help improve recovery for others who have experienced a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 6 months after the diagnosis of stroke
- • Independent walking over at least 7m with or without a walking aid
- • Mini-mental state examination score ≥ 24
- Exclusion Criteria:
- • Had difficulty in backward walking
- • Any neuromuscular disorders history
- • With visual or auditory disorders
- • Unstable cardiac status or uncontrolled hypertension
- • Any musculoskeletal disorders that would affect walking ability
About National Yang Ming Chiao Tung University
National Yang Ming Chiao Tung University is a prestigious research institution in Taiwan, recognized for its commitment to advancing healthcare and medical innovation. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with practical applications to address pressing health challenges. Its clinical trial sponsorship is characterized by rigorous scientific methodology, ethical standards, and a focus on improving patient outcomes. By fostering partnerships with healthcare providers and industry stakeholders, National Yang Ming Chiao Tung University plays a pivotal role in translating research findings into effective therapeutic solutions and enhancing the overall quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported